Cargando…
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
SIMPLE SUMMARY: Prognosis of advanced cutaneous squamous-cell carcinoma (CSCC) is poor. Recent clinical trials have shown that immunotherapy achieves significantly improved survival of patients with advanced CSCCs. However, few real-world data are available on treatment patterns and clinical outcome...
Ejemplares similares
-
Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck
Cancer Patients Treated With Chemoradiotherapy
por: Faravel, Kerstin, et al.
Publicado: (2023) -
Response to Somay et al. Letter to the Editor Regarding “Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy”
por: Faravel, Kerstin, et al.
Publicado: (2023) -
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
por: Becquart, Ondine, et al.
Publicado: (2021) -
Dramatic response of refractory metastatic squamous cell carcinoma of the
skin with cetuximab/pembrolizumab
por: Hober, Candice, et al.
Publicado: (2021) -
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
por: Kandel, Marguerite, et al.
Publicado: (2022)